PMC:7795966 / 21889-22997
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
777 | 315-319 | Gene | denotes | G6PD | Gene:2539 |
778 | 18-23 | Gene | denotes | MetHb | Gene:3048 |
779 | 576-584 | Species | denotes | patients | Tax:9606 |
780 | 645-652 | Species | denotes | patient | Tax:9606 |
781 | 937-945 | Species | denotes | patients | Tax:9606 |
782 | 75-86 | Chemical | denotes | chloroquine | MESH:D002738 |
783 | 90-108 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
784 | 189-200 | Chemical | denotes | chloroquine | MESH:D002738 |
785 | 228-246 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
786 | 415-433 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
787 | 601-612 | Chemical | denotes | chloroquine | MESH:D002738 |
788 | 617-635 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
789 | 840-854 | Chemical | denotes | methylene blue | MESH:D008751 |
790 | 900-914 | Chemical | denotes | Methylene blue | MESH:D008751 |
791 | 1004-1047 | Chemical | denotes | nicotinamide adenine dinucleotide phosphate | MESH:D009249 |
792 | 1049-1054 | Chemical | denotes | NADPH | MESH:D009249 |
793 | 1066-1080 | Chemical | denotes | methylene blue | MESH:D008751 |
794 | 1089-1099 | Chemical | denotes | -methylene | MESH:C030011 |
795 | 28-36 | Disease | denotes | COVID-19 | MESH:C000657245 |
796 | 211-226 | Disease | denotes | G6PD deficiency | MESH:D005955 |
797 | 468-483 | Disease | denotes | G6PD deficiency | MESH:D005955 |
798 | 688-703 | Disease | denotes | G6PD deficiency | MESH:D005955 |
799 | 707-722 | Disease | denotes | G6PD deficiency | MESH:D005955 |
800 | 881-898 | Disease | denotes | methemoglobinemia | MESH:D008708 |
801 | 953-968 | Disease | denotes | G6PD deficiency | MESH:D005955 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T43 | 881-898 | Phenotype | denotes | methemoglobinemia | http://purl.obolibrary.org/obo/HP_0012119 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T172 | 0-122 | Sentence | denotes | In the reports on MetHb and COVID-19 summarized in Section 3.2, the use of chloroquine or hydroxychloroquine is described. |
T173 | 123-501 | Sentence | denotes | In the case reported by Kuipers et al. [17], the subject received chloroquine and had a G6PD deficiency; hydroxychloroquine was administered to the subject reported by Faisal et al. [20] (the G6PD status was not reported); and in the three cases reported by Naymagon et al. [18] all received hydroxychloroquine, while one subject was tested for G6PD deficiency and was positive. |
T174 | 502-704 | Sentence | denotes | In the cases reported by Al-Aamri et al. [23] and Palmer et al. [22], the patients did not receive chloroquine and hydroxychloroquine, but the patient described by Al-Aamri et al. had a G6PD deficiency. |
T175 | 705-899 | Sentence | denotes | A G6PD deficiency is not only relevant with respect to the reaction to antiviral oxidizing drugs, but also for the effects of the drug methylene blue administered to treat the methemoglobinemia. |
T176 | 900-1108 | Sentence | denotes | Methylene blue may be ineffective in patients with a G6PD deficiency since they lack sufficient reduced nicotinamide adenine dinucleotide phosphate (NADPH) to reduce methylene blue to leuko-methylene [49,50]. |